Takeda's diabetes drug may not involve heart risk

07/11/2007 | Bloomberg

Study results expected soon may show Takeda Pharmaceutical's drug Actos does not have the heart-attack risk claimed for GlaxoSmithKline's Avandia. One study indicates Actos protects against blood clots that cause heart attacks, and a pending review of past studies may confirm the finding, a Takeda official said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA